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Purpose: As the proportion of early gastric cancer (EGC) has recently been increased, minimally invasive treatment is currently accepted 
as main therapy for EGC. Accurate preoperative staging is very important in determining treatment options. To know the accuracy of 
endoscopic ultrasonography (EUS), we compared the depth of invasion of the tumor with preoperative EUS and postoperative pathologic 
findings. 
Materials and Methods: We retrospectively analyzed 152 patients who underwent EUS before laparoscopic gastrectomy. The preopera-
tive EUS results were compared with the pathological findings.
Results: The overall proportion of coincidence for depth of invasion between EUS and pathologic results was 41.4%. Univariate analysis 
showed that the rate of corrected prediction of EUS for tumor depth significantly decreased for the lesions more than 3cm in diameter 
(P=0.033), and those with a depressed morphology (P=0.035). In multivariate analysis, the depressed type (P=0.029, OR=2.873) 
and upper lesion (P=0.035, OR=2.151) was the significantly independent factors influencing the inaccurate prediction of EUS for tu-
mor depth.
Conclusions: When we decide the treatment modality considering the clinical depth of invasion by EUS, the possibility of discordance 
with pathologic results should be considered for the lesions located in the upper third of the stomach and with a depressed morphology.
Key Words: Stomach neoplasms, Endosonography, Neoplasm invasiveness
J Gastric Cancer 2011;11(2):109-115  DOI:10.5230/jgc.2011.11.2.109
Correspondence to: Sang-Uk Han
Department of Surgery, Ajou University Hospital, San-5, Wonchon-
dong, Yeongtong-gu, Suwon 422-749, Korea
Tel: +82-31-219-5207, Fax: +82-31-219-5767
E-mail: hansu@ajou.ac.kr
Received May 23, 2011
Accepted June 1, 2011
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
Gastric cancer is one of the most common malignant tumors, 
and 5-year survival rate has been reported to be approximately 27-
52%.(1,2) The overall prognosis is still poor, nonetheless, recently, 
the trend is that treatment outcomes are on the improvement due to 
early diagnosis and appropriate treatments.(2) The treatment meth-
ods and prognosis of gastric cancer are determined by the level 
of local infiltration of tumors, lymph node metastasis, and distant 
metastasis. As the detection rate of early gastric cancer is increased 
and to improve quality of life, endoscopic mucosal resection (EMR), 
endoscopic submucosal dissection (ESD), laparoscopic gastrectomy, 
and other minimal invasive treatment methods are selected more. 
To determine such treatment methods, results of the studies that 
analyzed the role of endoscopic ultrasonography (EUS) have been 
reported.(3-5)
The Japanese Gastric Cancer Association (JGCA) has sug-
gested early gastric cancer that is differentiated adenocarcinoma, 
tumor size is smaller than 2 cm, depth of invasion is limited to the 
mucosal layer, and without ulcerous changes and without lymph 
node metastasis as indication for endoscopic dissection.(6) In addi-
tion, cases who are diagnosed as stage 1 gastric cancer (T1N1M0, 
T2N0M0) by the preoperative diagnosis of disease stage are indica-
tions for laparoscopic gastrectomy.(7) In order to select appropriate 
minimal invasive treatments, accurate preoperative diagnosis of 
disease stage is essential. For the diagnosis of T disease stage, the 
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accuracy of EUS is 78-93%, it is one of tests of which reliability is 
high, and its accuracy is higher than computed tomography (CT).
(8,9) EUS is useful to distinguish T1m from T1sm, and T1 from T2 
lesions. Nonetheless, the accuracy may be affected by endoscopic 
findings (microinfiltration of tumors, inflammatory changes in the 
vicinity of tumors, severe fibrosis associated with ulcers, benign 
ulcerous changes, benign cystic changes of the submucosal layer, 
deformity of the muscularis mucosa, insufficient tests, etc.), the 
location of lesions, the disease stage of gastric cancer, and research 
methods.(3,4,10)  
In this study, the authors discuss whether EUS is an appropriate 
marker that determines treatment approach through the accurate 
diagnosis of disease stage by analyzing the accuracy of EUS as well 
as factors that exert effects on the accuracy of EUS for the preop-
erative diagnosis of local disease stage of early gastric cancer.
Materials and Methods
Selected among patients who underwent laparoscopic gastrec-
tomy at the Ajou university hospital from February 2007 to January 
2010, this study was conducted retrospectively on 152 patients who 
underwent EUS for the determination of local disease stage prior 
to surgery. At our hospital, when gastric cancer is definitely diag-
nosed by endoscopic examination and histological tests, EUS and 
CT are performed to determine clinical disease stages. In the year 
of 2003 when laparoscopic surgery was initiated, indication was 
limited to early gastric cancer. Recently, with the accumulation of 
experiences, the principle is to perform laparoscopic gastrectomy 
on cases whose T stage assessed by EUS is lower than T3, and N 
stage assessed by CT is lower than N1, excluding lesions that are 
indication of endoscopic resection suggested by the JGCA. By the 
analysis of the medical record of the subject patients, results of ra-
diological tests, and results of histological tests, the level of the local 
infiltration of cancer, lymph node metastasis, and the accuracy of 
the preoperative evaluation of disease stage were examined. In ad-
dition, to examine the factors that exert effects on the accuracy of 
the preoperative evaluation of the diagnosis of disease stage, the 
accuracy of preoperative EUS evaluation according to tumor size, 
location, macroscopic morphology, and histological findings was 
compared and analyzed. The macroscopic morphology of tumors 
was evaluated according to the JGCA classification. It was defined 
that the elevated type was early gastric cancer type I, the depressed 
type was type III, the flat type was type II, and the mixed type was 
the combination of more than 2 types of the above basic types.(11) 
Histological findings were classified according to the classification 
of W orld Health Organization (WHO), and poorly differentiated 
adenocarcinoma, mucinous adenocarcinoma, and signet ring cell 
adenocarcinoma were classified as undifferentiated types.(12) The 
final disease stages that were analyzed by the results of histologi-
cal tests were evaluated according to the tumor disease stage of the 
International Union against Cancer (UICC), 7th edition.(13)
1. Depth of invasion by EUS
EUS used in this study was the Ultrasound miniprobe UM-
3R (ultrasound frequency 20 MHz, depth 4 cm, Olymphus, Tokyo, 
Japan). After the pretreatment identical to the upper gastrointestinal 
endoscopic tests, assessing lesions by endoscopes was performed. 
Operators were an identical team consisting of gastroenterologists 
with the experiences more than 50 cases of endoscopic ultraso-
nography annually, and it was performed under the supervision of 
a mentor professor. The stomach wall was divided to 5 layers and 
examined by EUS. The local infiltration level of lesions was evalu-
ated by defining the sum of high echo of the first layer and the low 
echo of the 2nd layer as the mucosa (m), the high echo area of the 
3rd layer as the submucosa (sm), the low echo area of the 4th layer 
as the muscularis propria (pm), and the high echo layer of the 5th 
layer as the subserosa (ss) and the serosa (s).
2. Surgical methods
According to the Japanese gastric cancer treatment guideline, 
D1+β lymph node resection was performed for T1N0M0 lesions, 
and D2 lymph node resection was performed for lesions higher 
than T2N0M0.(14) For cases with tumors in the upper stomach, 
total gastrectomy was performed. As reconstruction methods, for 
total gastrectomy cases, Roux en Y reconstruction was performed. 
For subtotal gastrectomy cases, Roux en Y, Billroth-I and Billroth-
II reconstruction were performed.
3. Statistical analysis
For statistical analysis of the data, the SPSS ver. 18.0 (SPSS Inc., 
Chicago, IL, USA) was used. For the analysis of the association of 
clinical characteristics with the accuracy of  EUS, univariate analy-
sis was performed by chi-square test, and multivariate analysis was 
performed by binary logistic regression analysis. P-value lower 
than 0.05 was defined as statistically significant levels.Efficacy of EUS for Gastric Cancer
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Results
1. Patients' feature, endoscopic gross type and endo­
scopic ultrasound finding
Characteristics of the subject patient groups and characteristics 
of the lesions are shown in Table 1. The mean age of patients was 
58 years (27~77 years), the male was 100 patients and the female 
was 52 patients. The average tumor size was 2.5 cm (0.2~8.0 cm). 
In regard to the location of tumors, the upper stomach was 11 
cases (7.2%), the middle area was 53 cases (34.9%), and the lower 
stomach was 88 cases (57.9%). Concerning gross morphology of 
tumors, the flat type (type II) was 94 cases (61.8%), which was 
most prevalent, the depressed type (type III) was 29 cases (19.1%), 
the mixed type was 25 cases (16.4%), and the elevated type (type I) 
was 4 cases (2.6%), which was least prevalent. Endoscopic ultraso-
nographic results were that sm  lesion was 65 cases (42.8%), which 
was most prevalent, m lesion was 47 cases (30.9%), pm lesion was 
26 cases (17.1%), and ss  lesion was 14 cases (9.2%).
2. Surgical and pathologic results
In regard to gastrectomy methods, total gastrectomy was 9 cases 
(5.9%), subtotal gastrectomy was 142 cases (93.4%), and wedge 
resection was 1 case (0.7%) (Table 2). The 1 case who received 
wedge resection had a m lesion in the upper stomach in EUS, and 
endoscopic resection was performed. Nonetheless, after surgery, 
due to perforation, emergency laparotomy and wedge resection 
were performed, and pathological results were a sm lesion. Patho-
logical findings of patients were that the differentiated type was 62 
cases (40.8%), and the undifferentiated type was 89 cases (58.6%). 
Concerning  T disease stages, T1 lesion was 119 cases (78.3%), and 
the lesion higher than T2 were 32 cases (21.0%). Histological find-
Table 1. Patients clinicopathologic characteristics (N=152)
Variable N (%)
Median age (years)   58 (27~77)
Gender 
   Male  100 (65.8)
   Female    52 (34.2)
Tumor size (histologically, cm)  
   Median  2.5 (0.2~8.0)
   >3 cm   43 (28.3)
   ≤3 cm 109 (71.7)
Tumor location
   Upper third   11 (7.2)
   Middle third   53 (34.9)
   Lower third   88 (57.9)
Gross type
   Elevated     4 (2.6)
   Depressed    29 (19.1)
   Flat       94 (61.8)
   Mixed   25 (16.4)
EUS layer
   Mucosa   47 (30.9) 
   Submucosa   65 (42.8)
   Proper muscle   26 (17.1)
   Subserosa   14 (9.2)
EUS = endoscopic ultrasonography.
Table 2. Operative procedure and pathological findings (N=152)
Variable N (%)
Operative procedure
   Total gastrectomy     9 (5.9)
   Distal subtotal gastrectomy 142 (93.4)
   Other     1 (0.7)
Reconstruction
   Roux en Y   22 (14.5)
   B-I   93 (61.2)
   B-II   36 (23.7)
   Other     1 (0.7)
Tumor depth
   Mucosa   72 (47.4)
   Submucosa   47 (30.9)
   Proper muscle   17 (11.2)
   Subserosa   11 (7.2)
   Serosa exposure     4 (2.6)
   Undetermined     1 (0.7)
Histology*
   Differentiated   62 (40.8)
   Undifferentiated   89 (58.6)
Final stage
†
   IA 102 (67.1)
   IB   30 (19.7)
   IIA     6 (3.9)
   IIB     7 (4.6)
   IIIA     3 (2.0)
   IIIB     2 (1.3)
   IIIC     2 (1.3)
*WHO international histological classification(1997); 
†Stage was 
described according to the 7th Edition of AJCC classification.Park JM, et al.
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ings could not be found in 1 case. The 1 case whose histological 
results could not be found was early gastric cancer in the middle 
anterior stomach wall, and by endoscopic histological tests, it was 
confirmed to be adenocarcinoma, and it was confirmed to be sm 
by EUS, and thus laparoscopic subtotal gastrectomy with billroth 
II gastrojejunostomy was performed. Nonetheless, in pathologi-
cal findings, only ulcers were detected and residual cancer was not 
detected. The final disease stage of 132 cases (86.8%) was stage 1 
gastric cancer.
3.  Diagnosis of tumor depth by EUS comparing with 
pathologic results
In the entire 152 cases, cases whose EUS results concurring to 
pathological T disease stage were 63 cases (41.4%), underestima-
tion was 32 cases (21.1%), and overestimation was 57 cases (37.5%). 
According to tumor size, in  46.8% of patients with tumors smaller 
than 3cm, EUS concurred to pathological results. Regarding cases 
larger than 3 cm, in only 27.9% cases, EUS concurred to patho-
logical findings (P=0.033). In addition, in cases with tumors in the 
upper stomach or in the distal stomach, the concurrence rate of 
EUS was shown to be lower than the body area cases, nonetheless, 
statistical significances were not shown (P=0.096). When analyzed 
according to macroscopic morphology, regarding  the depressed 
type, only in 24.1% cases, it concurred to pathological findings, 
and thus it was statistically significant (P=0.035). On the other 
hand, in the analysis of the concurrence rate of EUS to pathologi-
cal results according to histological findings, the differentiated type 
was 33.9%, the undifferentiated type was 47.2%, and statistically 
significant differences were not shown (P=0.102) (Table 3). In mul-
tivariate analysis, tumors located in the upper stomach (P=0.035) 
and tumors of which macroscopic morphology was the depressed 
type (P=0.029) were shown to be factors that could predict the 
discordance of EUS to histological findings, and particularly, cases 
with depressed macroscopic morphology were the most significant 
factor (OR=2.873) (Table 4).
4. Overestimate and underestimate by EUS
When cases with the inaccurate evaluation of tumor infiltration 
by EUS were analyzed, in cases that tumors were located in the 
upper stomach, 62.5% cases were underestimated. In cases with 
non-depressed macroscopic morphology, 77.6% cases were un-
Table 3. Proportion of corrected diagnosis for tumor depth by EUS comparing with the pathologic results
n Correctly diagnosed (%) Incorrectly diagnosed (%) P-value
Tumor size 0.033
   >3 cm   43 12 (27.9)  31 (72.1)
   ≤3 cm 109 51 (46.8)  58 (53.2)
Tumor location 0.096
   Upper third   11   3 (27.3)    8 (72.7)
   Middle third   53 28 (52.8)  25 (47.2)
   Lower third   88 32 (36.4)  56 (63.6)
Gross type 0.035
   Depressed     29   7 (24.1)  22 (75.9)
   Non-depressed 123 56 (45.5)  67 (54.5)
Histology* 0.102
   Differentiated   62 21 (33.9)  41 (66.1)
   Undifferentiated   89 42 (47.2)  47 (52.8)
WHO = World Health Organization. *WHO international histological classification (1997). 
Table 4. Multivariate analysis of the factors influencing the discor­
dance of EUS for pathologic tumor depth
Variable P-value Odd ratio 95% CI
Tumor size
   ≤3 cm vs. >3 cm 0.106 1.920 0.870~4.238
Tumor location
   Middle vs. Lower 0.141 2.986   0.695~12.831





EUS = endoscopic ultrasonography; CI = confidence interval.Efficacy of EUS for Gastric Cancer
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derestimated. On the other hand, when tumors were located in the 
body area or the lower area, 60.0% and 69.6%, respectively, were 
overestimated. In cases with non-depressed macroscopic mor-
phology, 77.6% cases were overestimated. In cases that histological 
findings were the differentiated type, 70.7% cases were overesti-
mated (Table 5).
Discussion
In Asia including Korea and Japan, the rate of the early diag-
nosis of gastric cancer becomes high, and with the increased ratio 
of patients older than 70 years whose postoperative complications 
and mortality rate are relatively high, endoscopic treatments for 
gastric cancer or minimal invasive treatments such as laparoscopic 
surgery became common procedure.(5,15) In gastric cancer, lymph 
node metastasis is determined by tumor infiltration levels, and thus 
for such minimal invasive treatments, differentiation of T1m from 
T1sm, and differentiation of T1 from T2 lesion are important.(3) 
In the past, local infiltration levels were evaluated by clinical find-
ings, CT, magnetic resonance imaging (MRI), etc., nonetheless, 
their accuracy is not high.(2,3) EUS examines the stomach wall 
by dividing each layer and thus it could evaluate the level of tumor 
infiltration more accurately. Hence, in the preoperative diagnosis of 
disease stage of gastric cancer, attentions have been focused on the 
accuracy and usefulness of EUS, and several studies have reported 
that EUS is useful for the diagnosis of local disease stage of gastric 
cancer.(2,4,5,16) EUS diagnoses the T stage of tumors depending 
on the depth of infiltration that destroys the normal layer structure 
of stomach wall by the low echo irregular mass findings.(17) Al-
though it is different depending on the literature, for the diagnosis 
of the T stage of gastric cancer, the accuracy of EUS has been 
reported to be 65-92%, and it may be influenced by several factors.
(4) In our study, in the evaluation of the local infiltration level of 
tumors, the accuracy of EUS was 41.4%, and EUS was performed 
by surgeons with abundant experiences, nonetheless, it was shown 
to be lower than the studies that have been reported until now. 
Until now, most clinical studies that examined the accuracy of EUS 
were conducted exclusively on the specific part of depth of invasion 
or studies that analyzed the accuracy on T stages.(4,5,16,17) It could 
be anticipated that in our study, it was analyzed including all types 
of infiltration depth that could be classified, and thus lower concur-
rence rates were shown in comparison with past studies. 
Kim et al.(18) have reported that in cases with tumors of which 
macroscopic morphology was depressed type, cases associated with 
ulcer, or cases of which histological findings were undifferenti-
ated, the accuracy of EUS was lowered, nonetheless, tumor size or 
location did not exert effects on the accuracy of EUS. On the other 
hand, Kim(3) have reported that in regard to the size of lesion, the 
accuracy of EUS was decreased in cases with lesions larger than 
3 cm. Tsuzuki et al.(4) have reported that in cases with tumors 
located in the upper stomach, the accuracy of EUS was decreased 
significantly, nonetheless, the accuracy of EUS in the differentiated 
type and the undifferentiated type were not different. Tsuzuki et 
al.(4) have reported that in the entire 104 patients who underwent 
EUS prior to surgery, the accuracy of EUS was 86%, EUS un-
derestimated the cases with lesions located in the upper stomach, 
overestimated lesions in the lower stomach, and underestimated the 
surface depressed type. 
In our study, in univariate analysis, factors that exerted effects 
on the accuracy of EUS were tumor size, location, and macro-
scopic morphology. In multivariate analysis, tumor location and 
macroscopic morphology were analyzed to be significant factors, 
and results similar to the studies that were reported until now were 
shown. In regard to tumors located in the upper stomach, it was 
underestimated more than overestimated (62.5% vs. 37.5%), which 
is determined to be due to that as stated in previously reported 
studies, the submucosa of upper stomach is relatively thin, and 
due to fibrosis or blood vessels, infiltration to the submucosa may 
not be detected.(4) Lesions of which macroscopic morphology is 
Table 5. Summary of the underestimation and overestimation of the 
tumor depth in incorrectly diagnosed patients
Underestimated (%) Overestimated (%)
Tumor size
   > 3cm 13 (41.9) 18 (58.1)
   ≤ 3cm 19 (32.8) 39 (67.2)
Tumor location
   Upper third   5 (62.5)   3 (37.5)
   Middle third 10 (40.0) 15 (60.0)
   Lower third 17 (30.4) 39 (69.6)
Gross type
   Depressed   17 (77.3)   5 (22.7)
   Non-depressed 15 (22.4) 52 (77.6)
Histology*
   Differentiated 12 (29.3) 29 (70.7)
   Undifferentiated 20 (42.6) 27 (57.4)
WHO = World Health Organization. *WHO international histological 
classification (1997). Park JM, et al.
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the depressed type, most of them may be associated with ulcerous 
changes, and thus it is underestimated more than the elevated type 
or the flat type.(18) 
It has been reported that the accuracy of EUS is lowered in 
undifferentiated adenocarcinoma. Kim et al. have reported that the 
accuracy of EUS was significantly reduced in undifferentiated cas-
es, and it showed a tendency to underestimate.(19) However, in our 
study, a trend that the accuracy of EUS for differentiated lesions 
was lower than undifferentiated lesions was shown, nonetheless, it 
was analyzed to be not significant statistically, and it is required to 
analyze more cases. Based on the results, it could be concluded that 
based on endoscopic findings, cases with lesions located in the up-
per area and cases with depressed macroscopic morphology, even if 
they are indication for endoscopic resection, appropriate treatment 
methods should be selected carefully considering the possibility that 
it may be underestimated by EUS. 
Of course, the analysis of the accuracy according to infiltra-
tion levels may be of help to select surgical methods, and thus its 
additional analysis may be of help. Nevertheless, the number of 
patients included in our study is too small to perform such analysis. 
In addition, all patients included in our study were patients who un-
derwent laparoscopic surgery for gastric cancer, and most patients 
had relatively early lesions that were not indication for endoscopic 
resection. Although prediction factors for concurrence were found 
by multivariate analysis in our study, it is considered if studies on a 
large number of gastric cancer patients with diverse disease stages 
are conducted in the future, it would be of help to conduct studies 
on the significance of EUS for the selection of treatment methods 
as well as to analyze the results of EUS. In addition, in our institu-
tion, preoperative assessment of lymph node metastasis has been 
performed by CT, nevertheless, EUS is valuable for the assessment 
of lymph node metastasis in the vicinity of the stomach, and thus it 
is considered that its clinical studies are required in the future.
In gastric cancer, for the selection of treatment methods such 
as endoscopic resection,  surgical treatments, the accurate diagnosis 
of disease stage prior to surgery is very important. In our study, in 
152 patients who underwent laparoscopic gastrectomy for gastric 
cancer, preoperative EUS findings and postoperative histological 
findings were compared. It was analyzed that in cases with tumors 
located in the upper area and the morphological type was depressed 
type, the accuracy of  EUS was low, and results similar to other 
investigators were obtained. Therefore, in cases with gastric cancer 
in the upper stomach and the depressed type, when endoscopic 
resection is considered based on EUS findings, it should be decided 
more carefully.
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